ATA Scientific Customer Installations

Monash University, Materials Science and Engineering recently installed their new desktop Phenom Pro SEM. The group is placed at the cutting edge where understanding material behaviour is the key to advances in many fields such as Biomedical engineering, Nanotechnology including additive manufacturing and 3D printing. The SEM will provide key insight into 3D printed alloys used for implants to optimise the bone interface with the metal surface.  

Griffith University has recently installed their new Theta Flex optical tensiometer with 3D Topography module used for surface roughness characterisation as well as to define roughness-corrected contact angle and surface free energy. The group works on materials development, silicon carbide microelectronics, micro-electromechanical systems and microfluidics to help develop cutting-edge technologies and improve people’s way of life.

UNSW is the first state in Australia to deliver a pilot manufacturing facility to support the establishment of a local RNA industry. Prof. Thordarson is director of the UNSW RNA Institute which brings together researchers from UNSW Science, Engineering and Medicine & Health. The NanoAssemblr platform will be used in the development of novel RNA therapeutics including cancer treatments along with RNA-based vaccines. 

Monash University, Department of Chemical and Biological Engineering has installed their new Micromeritics Autochem II 2920 Chemisorption Analyser. This fully automated instrument enables highly precise chemical adsorption and temperature- programmed reaction studies, ideal for studying catalysts. 

Monash, Clayton Campus at the School of Physics & Astronomy has installed their new desktop Phenom SEM Instrument. The group is developing new ways of imaging and designing advanced functional materials that will enable new discoveries and the understanding of complex systems. Tackling some of the most profound questions in science, researchers study the origin of space, time and matter. 

Funded by private donors to the Malaghan Institute of Medical Research, the NanoAssemblr Blaze was recently installed in Timaru at South Pacific Sera, a biotech that is part of Vaccine Alliance Aotearoa New Zealand – Ohu Kaupare Huaketo (VAANZ). The NanoAssemblr Blaze will be used during the development of new vaccines to produce mRNA encapsulated lipid nanoparticles. This is the first of its kind in New Zealand which brings the group one step closer in their quest to develop new therapeutic drugs.